Prometheus overcomplicated the Alien movie lore, and the franchise has yet to address all of those unanswered questions.

Merck & Co said on Sunday it will buy Prometheus Biosciences Inc for about $10.8 billion, picking up a promising experimental treatment for ulcerative colitis and Crohn's disease and building up ...

Merck said Sunday that it will acquire Prometheus Biosciences for $10.8 billion, adding a pipeline of experimental drugs to treat immune-related diseases. The deal values Prometheus at $200 per ...

Four University of Colorado Boulder academics, Jeff Cameron, Sherri Cook, Mija Hubler and Wil Srubar — all Prometheus cofounders and advisors — stumbled onto the idea while searching for a solution to ...